On The Peter Attia Drive, Dr. Sanjay Mehta sheds light on the evolving role of radiation in cancer treatment and emerging therapies. Mehta explains how advancements like linear accelerators and imaging techniques have made radiation more precise and less invasive for conditions like breast and prostate cancers. He also explores the use of low-dose radiation therapy for reducing inflammation in injuries and conditions like tendonitis.
The conversation tackles public misconceptions about radiation exposure and health risks. Mehta provides historical context for radiophobia in the U.S. and discusses evidence challenging the Linear No-Threshold model for radiation exposure thresholds. The discussion offers insights into minimizing radiation exposure in medical settings while maintaining diagnostic quality.
Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Dr. Sanjay Mehta explains how radiation oncology has advanced, with linear accelerators (LINACs) replacing cobalt-60 machines for improved precision and safety. Intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) optimize beams to precisely sculpt radiation doses to tumor sites while sparing healthy tissue. Simulation practices have also evolved to enhance radiation accuracy.
Mehta highlights the shift from radical mastectomies to breast conservation methods like lumpectomies combined with targeted radiation. Current treatments minimize long-term side effects while achieving comparable outcomes to mastectomies.
For prostate cancer, radiation has become more conformal and precise, drastically reducing side effects by sparing sensitive areas. Gel spacers further minimize radiation to the rectum. Advanced imaging and systemic therapies aid in monitoring and targeting recurrent disease.
Mehta discusses low-dose radiation therapy's (LDRT) use in Europe for inflammatory conditions like Achilles tendinopathy and plantar fasciitis. LDRT delivers a total of 3 Gy of fractionated, low-energy radiation over two weeks, potentially modulating cytokines, immune cells, and stimulating tissue repair to reduce inflammation and pain.
Mehta cites LDRT's efficacy, providing durable pain relief and functional improvements while avoiding side effects associated with higher doses. He notes the socio-economic impact of inflammatory conditions and the increasing insurance coverage for LDRT due to its therapeutic benefits.
Attia and Mehta explore the public radiophobia in the U.S., tracing it to historical events like the Radium Girls incident and nuclear accidents like Chernobyl and Three Mile Island. They question the Linear No-Threshold (LNT) model, citing evidence of hormesis and higher radiation thresholds at low doses.
Regarding medical imaging, Mehta highlights advancements minimizing radiation exposure in CT and PET-CT scans while maintaining diagnostic quality. He notes that radiation exposure for medical workers is now negligible due to shielding, remote operations, and strict regulations.
1-Page Summary
Peter Attia, interviewing Dr. Sanjay Mehta, discusses significant strides in the field of radiation oncology that are minimizing side effects and enhancing the precision of cancer treatments.
Sanjay Mehta highlights that linear accelerators (LINACs) have replaced Cobalt-60 machines in the U.S. for the past 30 years due to their precision and safety. LINACs are electron guns that fire electrons into a tungsten target to generate X-rays. Cobalt machines, which exposed patients to radioactive isotopes, have largely been decommissioned because LINACs offer higher energy photons and lower skin doses. Although Gamma Knife, which uses Cobalt-60, is still used by some centers for high-resolution treatment, LINAC-based stereotactic radiosurgery has largely replaced it due to its flexibility in treating more than just central nervous system conditions.
Mehta explains the use of advanced technologies like IMRT (intensity-modulated radiation therapy) and IGRT (image-guided radiation therapy). IMRT allows for high-definition treatment with multiple small "pixels" to precisely sculpt radiation doses. IGRT provides advanced targeting capabilities with the newest form of IMRT.
The careful positioning of patients for treatment sessions and advancements in simulation practices were highlighted by Mehta. He discusses the "movie star pose" for breast cancer radiation and the use of devices like vaclocks to create exact molds of a patient’s treatment position, ensuring accuracy and consistency. Modern radiation planning has eliminated the use of grease pencils and physical films, allowing for precisely directed beam angles that spare healthy tissue.
The conversation with Mehta and Attia showcases the evolution from radical mastectomies to breast conservation methods like lumpectomies combined with radiation therapy. Current radiation treatments are fractionated into small daily amounts over three weeks with optimized doses and schedules, resulting in mastectomy-like outcomes but with minimal long-term side effects.
Modern techniques further improve sparing of the heart, lungs, and other organs at risk during breast cancer radiation. Specialized therapies, like treating large-breasted patients prone, ensure that the radiation maximizes efficiency while minimizing unwanted exposure. These conservative approaches have been supported by evidence indicating that a combination of lumpectomy and radiation therapy leads to the same survival outcomes as total mastectomy.
Discussing prostate cancer, Mehta emphasizes the increased precision of radiation therapy, allowing for very low doses to the sensitive areas such as the penile bulb, rectum, and bladder. This precision has reduced side effects significantly. The introduction of gel spacers helps minimize the dose received by the rectum during treatment.
Patients are advised to prepare for treatment by maintaining a full bladder and empty bowel, which helps to maximize distances between prostate and surrounding organs. Mehta notes that modern radiation planning accounts for ...
Advancements and Innovations in Radiation Oncology
The podcast explores the therapeutic role of low-dose radiation therapy (LDRT) in treating various inflammatory conditions, with a focus on how it is more commonly used in Europe compared to the United States.
Peter Attia introduces the concept of utilizing low-dose radiation for healing injuries and expresses curiosity about its infrequent use in the U.S. for managing orthopedic issues.
The treatment mentioned by Mehta and Attia consists of 0.5 Gy given six times over two weeks, using very low-energy equipment like electron beam therapy. This results in a total of 3 Gy of radiation to the afflicted area.
The therapy's anti-inflammatory effect is likened to that of cortisone injections or NSAIDs. It works potentially by modulating cytokines, immune cells, and stimulating tissue repair.
Mentioning his own experience, Mehta shares that LDRT offers durable pain relief and functional improvements, and serves as an alternative to steroid injections.
For conditions not involving arthritis, like De Quervain's tenosynovitis and plantar fibrosis, radiation is also effective without causing side effects such as lymphedema linked with higher doses.
Protocols suggest reassessing the necessity for additional treatment 12 weeks post-therapy. The tr ...
Low-dose Radiation to Treat Inflammation
Peter Attia and Sanjay Mehta confront the deep-seated public fears—radiophobia—surrounding radiation, tracing it back to historical events and challenging misconceptions with current scientific understanding.
Attia and Mehta delve into the origins of radiophobia in the U.S., contrasting it with Europe where radiation is used routinely for non-cancerous conditions like arthritis and tendonitis. They attribute part of the fear to the Cold War's nuclear phobia and incidents like those involving the Radium Girls in the 1920s, who suffered from serious health issues like osteo-radionecrosis after ingesting radium. These cases, along with the broader use of radiation in products showing harmful effects, have significantly contributed to the public's fear.
The Linear No Threshold Model (LNT), suggesting any amount of radiation exposure carries some cancer risk, is questioned. Mehta points out that low radiation doses seem to cause almost no biological damage, challenging the LNT's notion of a directly proportional risk. The idea of hormesis, where low doses of radiation might have beneficial effects, is also explored, although its acceptance is controversial and primarily based on animal studies. Population studies around Hiroshima and Nagasaki suggest a potential radioprotection effect, with some individuals presenting lower rates of leukemia and thyroid cancer than expected.
Peter Attia highlights substantial reductions in CT scan radiation exposure due to advancements in technology. He notes a decline from 25 millisieverts in older CT angiograms to only 1 to 3 millisieverts with modern scanners. Mehta agrees, suggesting that while following the ALARA principle, the difference in cancer risk between the higher and lower doses isn't clear due to a lack of data. He emphasizes that the diagnostic quality of the image should be the priority.
Mehta also highlights the evolution of PET CT scans, noting how the amalgamation of anatomical data from CTs with PET data, while increasing radiation dose, is justified due to the enhanced resolution and more detailed results it produces.
The History and Misconceptions Surrounding Radiation Exposure
Download the Shortform Chrome extension for your browser